You turn off the light, close your eyes, and your mind keeps going. If lying awake waiting for sleep is familiar, you may have wondered whether melatonin, the body's own night-time signal, can help. A published meta-analysis offers a measured answer.
The study at a glance
- Who: Ferracioli-Oda E, Qawasmi A, Bloch MH.
- Where: PLOS ONE, 2013; 8(5): e63773 – "Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders".
- Design: Meta-analysis of randomized, placebo-controlled trials.
- Size: 19 studies, 1,683 participants (adults and children with primary sleep disorders).
What the research shows
Across the pooled studies, melatonin was associated with a shorter time to fall asleep: a weighted mean difference of about 7.06 minutes (95% CI 4.37 to 9.75) compared with placebo. Total sleep time was about 8.25 minutes longer (95% CI 1.74 to 14.75), and overall sleep quality showed a small improvement (standardized mean difference 0.22).
The authors also reported that trials with longer duration and higher doses tended to show larger effects on sleep latency and total sleep time, while dose and duration did not significantly change the sleep-quality result.
It is worth being honest about the size of these effects: they are modest, averaged across many people, and individual experiences vary. The analysis pooled several primary sleep disorders and included both adults and children, so it should not be read as a promise for any one person or condition.
Why it may work
Melatonin is a hormone your brain releases in the evening as light fades. It is thought to act as a timing signal for the body's internal clock, helping tell your system that night is approaching. Taking a small amount in the evening may support that signal, which is one reason researchers study it for sleep onset. Bright screens and irregular schedules can blunt the natural signal, so habits matter too.
Real-world use
Studies like this suggest melatonin is better thought of as a gentle timing aid than a sedative. It tends to work best alongside consistent bedtimes, a dim, cool room and less evening screen time.
Where Gudslip fits in
The Gudslip® Melatonin Gummies offer 1 mg of melatonin per berry-flavored gummy, in a pack of 30. We share the study to explain the mechanism, not to claim that our gummies will produce the same results; the trials tested melatonin in general, not this specific product.
How to use it
- Take as directed on the label, typically shortly before your intended bedtime.
- Keep your bedtime consistent and dim the lights in the hour before.
- Start with the lowest suitable amount and avoid exceeding the label directions.
- Pause and speak with a professional if you are pregnant, breastfeeding, taking medication, or have a health condition.
FAQ
Is 7 minutes a big difference?
It is an average across studies, so some people may notice more and others less. It is a modest effect, which is why habits and environment still matter.
Does a higher dose always work better?
The authors noted larger effects in trials using higher doses, but that does not mean more is better for you. Follow label directions and ask a professional.
Can children take melatonin?
The meta-analysis included children, but use in children should only be under professional guidance.
Does melatonin replace good sleep habits?
No. It is best viewed as a complement to regular timing, darkness and a calm routine.
When should I take it?
Timing is usually shortly before bed, but follow the product label and professional advice.
The bottom line
Pooled evidence from 19 placebo-controlled studies suggests melatonin may help people fall asleep somewhat sooner and sleep slightly longer, with small average effects. It is a supportive tool, not a cure-all.
Disclaimer: This article is for general wellness information only and is not medical advice. Gudslip products are not intended to diagnose, treat, cure or prevent any disease. Please consult a healthcare professional before using melatonin, especially if you are pregnant, breastfeeding, taking medication or have a medical condition.
References
- Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLOS ONE. 2013;8(5):e63773. doi:10.1371/journal.pone.0063773. https://pmc.ncbi.nlm.nih.gov/articles/PMC3656905/